Hypertension in women

Advances in Chronic Kidney Disease

Volumn 20, Issue 5, 2013, Pages 396-401

  August, Phyllis ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK HOSPITAL QUEENS   (United States)

Author keywords

Estrogen; Hormone replacement; Hypertension; Oral contraceptive pills; Women

Indexed keywords

ANGIOTENSINOGEN; ANTIHYPERTENSIVE AGENT; CONJUGATED ESTROGEN; ETHINYLESTRADIOL; GESTAGEN;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BORDERLINE HYPERTENSION; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); COUGHING; DISEASE ASSOCIATION; DIURETIC THERAPY; ESTROGEN THERAPY; FIBROMUSCULAR DYSPLASIA; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MATERNAL HYPERTENSION; NONHUMAN; OBESITY; ORAL CONTRACEPTIVE USE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; REVIEW; SEX DIFFERENCE; SEXUAL DYSFUNCTION;

ESTROGEN; HORMONE REPLACEMENT; HYPERTENSION; ORAL CONTRACEPTIVE PILLS; WOMEN;

ADULT; AGED; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY;

EID: 84882780525     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2013.07.002     Document Type: Review

References (60)

1. Ong K.L., Tso A.W., Lam K.S., Cheung B.M. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension. Hypertension 2008, 51(4):1142-1148.
2. Olives C., Myerson R., Mokdad A.H., Murray C.J., Lim S.S. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One 2013, 8(4):e60308.
3. Kotchen J.M., McKean H.E., Kotchen T.A. Blood pressure trends with aging. Hypertension 1982, 4(5 Pt 2):III128-III134.
4. Vokonas P.S., Kannel W.B., Cupples L.A. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens Suppl 1988, 6(1):S3-S9.
5. Chapman A.B., Zamudio S., Woodmansee W., et al. Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 1997, 273(5 Pt 2):F777-F782.
6. Dunne F.P., Barry D.G., Ferriss J.B., Grealy G., Murphy D. Changes in blood pressure during the normal menstrual cycle. Clin Sci (Lond) 1991, 81(4):515-518.
7. Karpanou E.A., Vyssoulis G.P., Georgoudi D.G., Toutouza M.G., Toutouzas P.K. Ambulatory blood pressure changes in the menstrual cycle of hypertensive women. Significance of plasma renin activity values. Am J Hypertens 1993, 6(8):654-659.
8. August P., Lenz T., Ales K.L., et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990, 163(5 Pt 1):1612-1621.
9. Barton M., Meyer M.R. Postmenopausal hypertension: mechanisms and therapy. Hypertension 2009, 54(1):11-18.
10. Lieberman E.H., Gerhard M.D., Uehata A., et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994, 121(12):936-941.
11. Coylewright M., Reckelhoff J.F., Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 2008, 51(4):952-959.
12. Taddei S., Virdis A., Ghiadoni L., et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996, 28(4):576-582.
13. Owens J.F., Stoney C.M., Matthews K.A. Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993, 88(6):2794-2802.
14. Hjortland M.C., McNamara P.M., Kannel W.B. Some atherogenic concomitants of menopause: The Framingham Study. Am J Epidemiol 1976, 103(3):304-311.
15. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R. Menopause and risk factors for coronary heart disease. N Engl J Med 1989, 321(10):641-646.
16. Staessen J., Bulpitt C.J., Fagard R., Lijnen P., Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989, 3(6):427-433.
17. Lima R., Wofford M., Reckelhoff J.F. Hypertension in postmenopausal women. Curr Hypertens Rep 2012, 14(3):254-260.
18. Chen Y.F., Naftilan A.J., Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992, 19(5):456-463.
19. Reckelhoff J.F. Gender differences in the regulation of blood pressure. Hypertension 2001, 37(5):1199-1208.
20. Barton M. Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch 2010, 460(5):825-837.
21. Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M. The epidemiology of obesity. Gastroenterology 2007, 132(6):2087-2102.
22. Luoto R., Kaprio J., Reunanen A., Rutanen E.M. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol 1995, 85(4):515-522.
23. Laragh J.H., Sealey J.E., Ledingham J.G., Newton M.A. Oral contraceptives. Renin, aldosterone, and high blood pressure. JAMA 1967, 201(12):918-922.
24. Cardoso F., Polonia J., Santos A., Silva-Carvalho J., Ferreira-de-Almeida J. Low-dose oral contraceptives and 24-hour ambulatory blood pressure. Int J Gynaecol Obstet 1997, 59(3):237-243.
25. Dong W., Colhoun H.M., Poulter N.R. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994. J Hypertens 1997, 15(10):1063-1068.
26. Yu J., Hu X.H. Inappropriate use of combined hormonal contraceptives for birth control among women of reproductive age inthe United States. J Womens Health (Larchmt) 2013, 22(7):595-603.
27. Woods J.W. Oral contraceptives and hypertension. Hypertension 1988, 11(3 Pt 2):II11-II15.
28. Ramcharan S, Pellegrin FA, Hoag EJ. The occurrence and course of hypertensive disease in users and nonusers of oral contraceptive drugs. The Walnut Creek Contraceptive Drug Study: A prospective study of the side effects of oral contraceptives. 1976;2:1-16.
29. The WHO multicentre trial of the vasopressor effects of combined oral contraceptives. Contraception 1989, 40(2):147-156.
30. Chasan-Taber L., Willett W.C., Manson J.E., et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996, 94(3):483-489.
31. Curtis K.M., Mohllajee A.P., Martins S.L., Peterson H.B. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception 2006, 73(2):179-188.
32. Byrne K.B., Geraghty D.P., Stewart B.J., Burcher E. Effect of contraceptive steroid and enalapril treatment of systolic blood pressure and plasma renin-angiotensin in the rat. Clin Exp Hypertens 1994, 16(5):627-657.
33. Hussain S.F. Progestogen-only pills and high blood pressure: is there an association? A literature review. Contraception 2004, 69(2):89-97.
34. Crane M.G., Harris J.J., Winsor W. Hypertension, oral contraceptive agents, and conjugated estrogens. Ann Intern Med 1971, 74(1):13-21.
35. Notelovitz M. Effect of natural oestrogens on blood pressure and weight in postmenopausal women. S Afr Med J 1975, 49(55):2251-2254.
36. Utian W.H. Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight. Maturitas 1978, 1(1):3-8.
37. Pfeffer R.I. Estrogen use, hypertension and stroke in postmenopausal women. J Chronic Dis 1978, 31(6-7):389-398.
38. Crane M.G., Harris J.J. Estrogens and hypertension: effect of discontinuing estrogens on blood pressure, exchangeable sodium, and the renin-aldosterone system. Am J Med Sci 1978, 276(1):33-55.
39. Wren B.G., Routledge D.A. Blood pressure changes: oestrogens in climacteric women. Med J Aust 1981, 2(10):528-531.
40. Akkad A.A., Halligan A.W., Abrams K., al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997, 89(1):97-103.
41. Oelkers W., Schoneshofer M., Blumel A. Effects of progesterone and four synthetic progestagens on sodium balance and the renin-aldosterone system in man. J Clin Endocrinol Metab 1974, 39(5):882-890.
42. Lind T., Cameron E.C., Hunter W.M., et al. A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol 1979, 86(suppl 3):1-29.
43. Elias A.N., Meshkinpour H., Valenta L.J. Attenuation of hypertension by conjugation estrogens. Nephron 1982, 30(1):89-92.
44. Group P.T.W. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995, 273(3):199-208.
45. Lip G.Y., Beevers M., Churchill D., Beevers D.G. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994, 8(7):491-494.
46. Wassertheil-Smoller S., Anderson G., Psaty B.M., et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000, 36(5):780-789.
47. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003, 289(20):2673-2684.
48. Wassertheil-Smoller S. Stroke in women. Nutr Metab Cardiovasc Dis 2010, 20(6):419-425.
49. Slovut D.P., Olin J.W. Fibromuscular dysplasia. N Engl J Med 2004, 350(18):1862-1871.
50. Sos T.A., Pickering T.G., Sniderman K., et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983, 309(5):274-279.
51. Bentley-Lewis R., Seely E., Dunaif A. Ovarian hypertension: polycystic ovary syndrome. Endocrinol Metab Clin North Am 2011, 40(2):433-449.
52. Garovic V.D., August P. Preeclampsia and the future risk of hypertension: the pregnant evidence. Curr Hypertens Rep 2013, 15(2):114-121.
53. Lewis C.E., Grandits A., Flack J., McDonald R., Elmer P.J. Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study. Arch Intern Med 1996, 156(4):377-385.
54. Kanai H., Tokunaga K., Fujioka S., Yamashita S., Kameda-Takemura K.K., Matsuzawa Y. Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension 1996, 27(1):125-129.
55. Nestel P.J., Clifton P.M., Noakes M., McArthur R., Howe P.R. Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio. J Hypertens 1993, 11(12):1387-1394.
56. Turnbull F., Woodward M., Anna V. Effectiveness of blood pressure lowering: evidence-based comparisons between men and women. Expert Rev Cardiovasc Ther 2010, 8(2):199-209.
57. Pimenta E. Hypertension in women. Hypertens Res 2012, 35(2):148-152.
58. Anastos K., Charney P., Charon R.A., et al. Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 1991, 115(4):287-293.
59. Os I., Bratland B., Dahlof B., Gisholt K., Syvertsen J.O., Tretli S. Female sex as an important determinant of lisinopril-induced cough. Lancet 1992, 339(8789):372.
60. Ueno K., Sato H. Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs. Hypertens Res 2012, 35(3):245-250.